The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Inventiva Pharma; Inventiva Pharma; Inventiva Pharma; Inventiva Pharma
Consulting or Advisory Role - Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Aldeyra Therapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Inventiva Pharma; Inventiva Pharma; Inventiva Pharma; Inventiva Pharma
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Roche; Roche; Roche; Roche
Research Funding - Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim
Travel, Accommodations, Expenses - BMSi; BMSi; BMSi; BMSi; MSD; MSD; MSD; MSD
(OPTIONAL) Uncompensated Relationships - Atara Biotherapeutics (I); Atara Biotherapeutics (I)
A randomized phase II trial of olaparib maintenance versus placebo monotherapy in patients with chemosensitive advanced non-small cell lung cancer.
 
Dean A. Fennell
No Relationships to Disclose
 
Jason Francis Lester
Consulting or Advisory Role - BMSi; Boehringer Ingelheim; MSD; Roche
Travel, Accommodations, Expenses - MSD; Roche
 
Sarah Danson
No Relationships to Disclose
 
Fiona Helen Blackhall
No Relationships to Disclose
 
Marianne Nicolson
No Relationships to Disclose
 
Lisette Sheena Nixon
No Relationships to Disclose
 
Catharine Porter
Research Funding - AstraZeneca (Inst); Incyte (Inst); Merck (Inst); MSD Oncology (Inst)
 
Georgina Mary Gardner
No Relationships to Disclose
 
Ann White
No Relationships to Disclose
 
Gareth Owen Griffiths
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Patent on ASTEX drug working in new cancer area (Inst)
 
Angela Claire Casbard
Research Funding - AstraZeneca (Inst)